UK-CAB 40: Gender and HIV research


09:30–09:45 Registration, refreshments and expenses
09:45–10:00 Welcome, introductions, UKCAB updates, Company pre-meeting
10:00–10:30 Gender and HIV research: history and overview – Angelina Namiba, HIV i-Base
10:30–11.30 Outcomes in HIV positive women – Lucy Campbell, Kings College Hospital
11:30–11:40 Break
11:40–12:40 The XX factor – women and HIV – Prof. Jane Anderson, Homerton University Hospital
12:40–14:00 Lunch
14:00–15:30  Company meeting: BMS
15:30–15:35  Break
15:35–16:00 London HIV drug prescribing update and survey –Mark PlattUKCAB AOB
16.00 Close

Background reading:

1st International Workshop on Women From Adolescence through menopause

The full report from this meeting can be viewed online here:

Lopinavir/ritonavir LPV/r: women versus men
An analysis of on efficacy, safety and tolerability of LPV/r in women compared to men.

Lessons from GRACE: A US Study Focused on Women Living with HIV

GRACE is the largest HIV/AIDS study to date in North America of HIV treatment experienced women. The study looked at whether darunavir/ritonavir (DRV/r) in combination with other ARVs would have a different effect in women compared to men. Black women were the focus of the GRACE Study because of the disproportionate effect that HIV/AIDS has in this population throughout the US.

It also is reportedly the longest ongoing disease progression study of HIV infection in women.

Quality of life in the GRACE study
The report looks at the quality of life in the study participants and how it impacted on discontinuing the study and virological response.

Antiretroviral pharmacokinetics in women with undetectable viral load

This entry was posted in Meetings. Bookmark the permalink. Comments are closed, but you can leave a trackback: Trackback URL.